Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Melancholic Depression and Insomnia as Predictors of Response to Quetiapine in Patients With Major Depression

NCT03207438 is registered in ClinicalTrials.gov with University of Saskatchewan as lead sponsor.

NCT NCT03207438
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03207438 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Melancholic Depression and Insomnia as Predictors of Response to Quetiapine in Patients With Major Depression
Lead sponsor
University of Saskatchewan
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2006
Completion date
October 31, 2019
Enrollment
1,790 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

depressive disorder, major